Inventurus Knowledge Solutions Shares Jump Over 2% After Partnership With GI Alliance

IKS Health, a leader in care support solutions, has formed a partnership with GI Alliance, the largest independent gastroenterology group in the U.S. This collaboration aims to improve operations using AI-powered tools and human expertise, especially focusing on revenue cycle management (RCM) for GI and related specialities.

Benefits of the Collaboration

The partnership will help reduce the administrative workload of GI Alliance’s staff, allowing them to concentrate more on patient care. Both teams will work together to use top-level technology and systems to make medical and operational tasks more efficient.

About GI Alliance

GI Alliance is a physician-led and owned network that supports over 900 independent gastroenterologists across 345 locations in the U.S. It helps them manage their practices, expand services and engage patients while maintaining clinical freedom and delivering quality care.

About IKS Health

IKS Health provides solutions that handle administrative and operational tasks in healthcare, so doctors can focus on treating patients. Founded in 2006, IKS Health supports many large U.S. health systems through its technology and expert teams that will help to improve performance and cut costs.

Read More: Navin Fluorine and Chemours Partner on Liquid Cooling Product Manufacturing

Share Price Performance 

As of May 08, 2025, at 1:50 PM, Inventurus Knowledge Solutions Ltd share price is trading at ₹1,517.30 per share, reflecting a surge of 4.22% from the previous day’s closing price. Over the past month, the stock has surged by 11.77%.

Conclusion

The partnership between IKS Health and GI Alliance is a positive step toward improving healthcare. It will help doctors and staff work more easily and spend more time with patients. Both companies are looking forward to growing together and making healthcare better.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.